WebDisclosure WebDisclosure
Basculer en Français
10651 Companies
226549 Keywords
155030 Articles
119938 Press releases
Headlines Articles Press releases Propelus Remove
  1. Home
  2. Companies
  3. Propelus
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 04/30/2024 at 17:50, 2 years 1 month ago

    CE Broker de Propelus s'associe au Texas Medical Board pour améliorer la formation continue

    Conformité Des Soins De Santé Formation Continue Licence Professionnelle Courtier CE Conseil Médical Du Texas
  • PRESS RELEASE

    published on 04/30/2024 at 17:45, 2 years 1 month ago

    CE Broker by Propelus and Texas Medical Board Forge Alliance to Modernize Continuing Education

    CE Broker by Propelus announces strategic partnership with the Texas Medical Board to modernize continuing education management for licensed professionals. The collaboration aims to revolutionize the education process
    Partnership Continuing Education CE Broker Texas Medical Board Propelus
    Logo of Propelus
  • PRESS RELEASE

    published on 08/01/2023 at 14:00, 2 years 10 months ago

    Introducing Propelus: Healthcare Compliance Leader Unveils New Company Brand to Focus on Powering Professionals

    Logo of Propelus
Previous page
1 2
Accesswire
  • Published on 06/27/2026 at 16:50, 9 hours 27 minutes ago

    Redwood AI Announces Definitive Agreement with Quantum.IQ and Expands into Quantum Resistant Cyber Security

  • Published on 06/27/2026 at 01:40, 1 day ago

    Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting

  • Published on 06/27/2026 at 00:00, 1 day 2 hours ago

    Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010

  • Published on 06/26/2026 at 23:00, 1 day 3 hours ago

    Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting

  • Published on 06/26/2026 at 22:50, 1 day 3 hours ago

    Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada

View all ACCESSWIRE
EQS Group
  • Published on 06/27/2026 at 00:05, 1 day 2 hours ago

    EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss

  • Published on 06/27/2026 at 00:04, 1 day 2 hours ago

    Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering

  • Published on 06/26/2026 at 23:36, 1 day 2 hours ago

    Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering

  • Published on 06/26/2026 at 23:36, 1 day 2 hours ago

    EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share

  • Published on 06/26/2026 at 23:27, 1 day 2 hours ago

    EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE

View all EQS
Les Echos
  • Published on 06/26/2026 at 17:45, 1 day 8 hours ago

    Combined General Meeting, June 25, 2026

  • Published on 06/26/2026 at 17:45, 1 day 8 hours ago

    Assemblée générale mixte du 25 juin 2026

  • Published on 06/26/2026 at 17:45, 1 day 8 hours ago

    Descriptif du programme de rachat d'actions

  • Published on 06/26/2026 at 14:44, 1 day 11 hours ago

    Safran information

  • Published on 06/26/2026 at 14:44, 1 day 11 hours ago

    Information Safran

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy